Tapewire

NYSE · USD

BAX

BAXTER INTERNATIONAL INC

Export transactions ↓
Tapewire entity
1707
SEC CIK
0000010456
Parsed reports
561

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2021 Filed May 6, 2021 22:08 UTC GrantCommon Stock, $1 par value 1,116 $0.00 $0.00
Disclosure

SEC source: 0001262931-21-000001 · edgar.xml · nonDerivative · entry 1

FORSYTH JOHN D · CIK 0001262931 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,315

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. ("Company"), subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:07 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001842866-21-000003 · edgar.xml · nonDerivative · entry 1

Wilkes David S. · CIK 0001842866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,597

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:05 UTC GrantStock Option (Right to Buy) · Derivative 5,685 $0.00 Strike: $87.44 $0.00
Disclosure

SEC source: 0001400568-21-000001 · edgar.xml · derivative · entry 2

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,685

Underlying: Common Stock, $1 par value · 5,685 shares

Expires 2031-05-04

F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:05 UTC GrantCommon Stock, $1 par value 1,116 $0.00 $0.00
Disclosure

SEC source: 0001400568-21-000001 · edgar.xml · nonDerivative · entry 1

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,365

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. ("Company"), subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:04 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001205438-21-000002 · edgar.xml · nonDerivative · entry 1

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:03 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001124165-21-000001 · edgar.xml · nonDerivative · entry 1

STALLKAMP THOMAS T · CIK 0001124165 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,576

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:02 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001322028-21-000001 · edgar.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,475

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001174532-21-000001 · edgar.xml · nonDerivative · entry 1

Oesterle Stephen N. · CIK 0001174532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,495

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:59 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001204081-21-000001 · edgar.xml · nonDerivative · entry 1

MORRISON PATRICIA · CIK 0001204081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,370

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:58 UTC GrantStock Option (Right to Buy) · Derivative 5,685 $0.00 Strike: $87.44 $0.00
Disclosure

SEC source: 0001533022-21-000001 · edgar.xml · derivative · entry 3

Mahoney Michael F · CIK 0001533022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,685

Underlying: Common Stock, $1 par value · 5,685 shares

Expires 2031-05-04

F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:58 UTC GrantCommon Stock, $1 par value 1,116 $0.00 $0.00
Disclosure

SEC source: 0001533022-21-000001 · edgar.xml · nonDerivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,267

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. ("Company"), subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:56 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001107468-21-000003 · edgar.xml · nonDerivative · entry 1

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,629

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:55 UTC GrantCommon Stock, $1 par value 2,230 $0.00 $0.00
Disclosure

SEC source: 0001360147-21-000001 · edgar.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,857

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 20:04 UTC
Frye AndrewSVP, President, APAC
SaleCommon Stock, $1 par value 10,999 $84.79 $932,605.21
Disclosure

SEC source: 0001712314-21-000004 · edgar.xml · nonDerivative · entry 1

Frye Andrew · CIK 0001712314 · SVP, President, APAC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,041

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Frye with respect to certain vested restricted stock units previously granted by Baxter International Inc. ("BII") to Mr. Frye.

F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.38 through $85.02. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:57 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,990 $0.00 Strike: $31.26 $0.00
Disclosure

SEC source: 0001205438-21-000001 · edgar.xml · derivative · entry 4

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 4,990 shares

Expires 2021-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII') to Mr. Stroucken.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:57 UTC SaleCommon Stock, $1 par value 4,990 $84.56 $421,954.40
Disclosure

SEC source: 0001205438-21-000001 · edgar.xml · nonDerivative · entry 2

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,896

F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.35 through $84.75. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:57 UTC Exercise / conversionCommon Stock, $1 par value 4,990 $31.26 $155,987.40
Disclosure

SEC source: 0001205438-21-000001 · edgar.xml · nonDerivative · entry 1

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII') to Mr. Stroucken.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:55 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,990 $0.00 Strike: $31.26 $0.00
Disclosure

SEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 10

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 4,990 shares

Expires 2021-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Hellman with respect to certain vested stock options previously granted by BII to Mr. Hellman.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:55 UTC SaleCommon Stock, $1 par value 4,990 $84.56 $421,954.40
Disclosure

SEC source: 0001107468-21-000002 · edgar.xml · nonDerivative · entry 2

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,399

F6 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.34 through $84.75. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 22:55 UTC Exercise / conversionCommon Stock, $1 par value 4,990 $31.26 $155,987.40
Disclosure

SEC source: 0001107468-21-000002 · edgar.xml · nonDerivative · entry 1

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Hellman with respect to certain vested stock options previously granted by BII to Mr. Hellman.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 20:10 UTC
Stevens BrianSVP, CAO and Controller
Tax withholdingCommon Stock, $1 par value 155 $81.24 $12,592.20
Disclosure

SEC source: 0001557559-21-000004 · edgar.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,854

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 22, 2021 from the settlement of vested restricted stock units granted on March 20, 2020.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:20 UTC
Accogli GiuseppeSVP, Pres, Amer, Global Bus
GrantStock Option (Right to Buy) · Derivative 121,969 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001678067-21-000004 · edgar.xml · derivative · entry 1

Accogli Giuseppe · CIK 0001678067 · SVP, Pres, Amer, Global Bus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,969

Underlying: Common Stock, $1 par value · 121,969 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:15 UTC
Stevens BrianSVP, CAO and Controller
GrantStock Option (Right to Buy) · Derivative 17,424 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001557559-21-000003 · edgar.xml · derivative · entry 2

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,424

Underlying: Common Stock, $1 par value · 17,424 shares

Expires 2031-03-03

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:15 UTC
Stevens BrianSVP, CAO and Controller
GrantCommon Stock, $1 par value 1,750 $0.00 $0.00
Disclosure

SEC source: 0001557559-21-000003 · edgar.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,010

F1 · shares: The reporting person received a grant of 1,750 restricted stock units which are scheduled to vest in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2015 Incentive Plan.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:13 UTC
Mason Jeanne KSVP, Human Resources
GrantStock Option (Right to Buy) · Derivative 48,788 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001362109-21-000002 · edgar.xml · derivative · entry 1

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,788

Underlying: Common Stock, $1 par value · 48,788 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:14 UTC
SACCARO JAMESExecutive VP and CFO
GrantStock Option (Right to Buy) · Derivative 82,369 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001593636-21-000002 · edgar.xml · derivative · entry 1

SACCARO JAMES · CIK 0001593636 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,369

Underlying: Common Stock, $1 par value · 82,369 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:11 UTC
Martin SeanSVP and General Counsel
GrantStock Option (Right to Buy) · Derivative 63,360 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001500332-21-000002 · edgar.xml · derivative · entry 1

Martin Sean · CIK 0001500332 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,360

Underlying: Common Stock, $1 par value · 63,360 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:10 UTC
Kunzler JacquelineSVP, Chief Quality Officer
GrantStock Option (Right to Buy) · Derivative 31,680 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001779771-21-000003 · edgar.xml · derivative · entry 1

Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,680

Underlying: Common Stock, $1 par value · 31,680 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:09 UTC
Frye AndrewSVP, President, APAC
GrantStock Option (Right to Buy) · Derivative 79,201 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001712314-21-000002 · edgar.xml · derivative · entry 1

Frye Andrew · CIK 0001712314 · SVP, President, APAC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,201

Underlying: Common Stock, $1 par value · 79,201 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:08 UTC
Franzi CristianoSVP, President, EMEA
GrantStock Option (Right to Buy) · Derivative 79,201 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001715790-21-000002 · edgar.xml · derivative · entry 1

Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,201

Underlying: Common Stock, $1 par value · 79,201 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:06 UTC
Borzi James WSVP, Global Supply Chain
GrantStock Option (Right to Buy) · Derivative 44,352 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001495559-21-000001 · edgar.xml · derivative · entry 1

Borzi James W · CIK 0001495559 · SVP, Global Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,352

Underlying: Common Stock, $1 par value · 44,352 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:05 UTC
ALMEIDA JOSE EChairman, CEO and President
GrantStock Option (Right to Buy) · Derivative 348,483 $0.00 Strike: $77.15 $0.00
Disclosure

SEC source: 0001216761-21-000002 · edgar.xml · derivative · entry 1

ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,483

Underlying: Common Stock, $1 par value · 348,483 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:51 UTC
Stevens BrianSVP, CAO and Controller
Tax withholdingCommon Stock, $1 par value 201 $77.94 $15,665.94
Disclosure

SEC source: 0001557559-21-000002 · edgar.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,260

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 1, 2021 from the settlement of vested restricted stock units granted on February 28, 2019.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 21:10 UTC GrantCommon Stock, $1 par value 366 Not disclosed Not disclosed
Disclosure

SEC source: 0001842866-21-000002 · edgar.xml · nonDerivative · entry 1

Wilkes David S. · CIK 0001842866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366

F1 · shares: The reporting person received a grant of 366 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant.

F1 · price: The reporting person received a grant of 366 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:20 UTC
Accogli GiuseppeSVP, Pres, Amer and Glbl Bus
GrantCommon Stock, $1 par value 998 $0.00 $0.00
Disclosure

SEC source: 0001678067-21-000002 · edgar.xml · nonDerivative · entry 4

Accogli Giuseppe · CIK 0001678067 · SVP, Pres, Amer and Glbl Bus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,140

F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021).

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:20 UTC
Accogli GiuseppeSVP, Pres, Amer and Glbl Bus
Tax withholdingCommon Stock, $1 par value 3,173 $77.80 $246,859.40
Disclosure

SEC source: 0001678067-21-000002 · edgar.xml · nonDerivative · entry 3

Accogli Giuseppe · CIK 0001678067 · SVP, Pres, Amer and Glbl Bus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,142

F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:20 UTC
Accogli GiuseppeSVP, Pres, Amer and Glbl Bus
GrantCommon Stock, $1 par value 4,032 $0.00 $0.00
Disclosure

SEC source: 0001678067-21-000002 · edgar.xml · nonDerivative · entry 2

Accogli Giuseppe · CIK 0001678067 · SVP, Pres, Amer and Glbl Bus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,315

F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:20 UTC
Accogli GiuseppeSVP, Pres, Amer and Glbl Bus
GrantCommon Stock, $1 par value 1,101 $0.00 $0.00
Disclosure

SEC source: 0001678067-21-000002 · edgar.xml · nonDerivative · entry 1

Accogli Giuseppe · CIK 0001678067 · SVP, Pres, Amer and Glbl Bus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,283

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:16 UTC
Stevens BrianSVP, CAO and Controller
GrantCommon Stock, $1 par value 114 $0.00 $0.00
Disclosure

SEC source: 0001557559-21-000001 · edgar.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,461

F1 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021).

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:15 UTC
SACCARO JAMESExecutive VP and CFO
GrantCommon Stock, $1 par value 1,179 $0.00 $0.00
Disclosure

SEC source: 0001593636-21-000001 · edgar.xml · nonDerivative · entry 4

SACCARO JAMES · CIK 0001593636 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,458

F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021).

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:15 UTC
SACCARO JAMESExecutive VP and CFO
Tax withholdingCommon Stock, $1 par value 4,308 $77.80 $335,162.40
Disclosure

SEC source: 0001593636-21-000001 · edgar.xml · nonDerivative · entry 3

SACCARO JAMES · CIK 0001593636 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,279

F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:15 UTC
SACCARO JAMESExecutive VP and CFO
GrantCommon Stock, $1 par value 5,241 $0.00 $0.00
Disclosure

SEC source: 0001593636-21-000001 · edgar.xml · nonDerivative · entry 2

SACCARO JAMES · CIK 0001593636 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,587

F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:15 UTC
SACCARO JAMESExecutive VP and CFO
GrantCommon Stock, $1 par value 1,432 $0.00 $0.00
Disclosure

SEC source: 0001593636-21-000001 · edgar.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,346

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:13 UTC
Mason Jeanne KSVP, Human Resources
GrantCommon Stock, $1 par value 603 $0.00 $0.00
Disclosure

SEC source: 0001362109-21-000001 · edgar.xml · nonDerivative · entry 4

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,145

F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021).

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:13 UTC
Mason Jeanne KSVP, Human Resources
Tax withholdingCommon Stock, $1 par value 2,004 $77.80 $155,911.20
Disclosure

SEC source: 0001362109-21-000001 · edgar.xml · nonDerivative · entry 3

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,542

F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:13 UTC
Mason Jeanne KSVP, Human Resources
GrantCommon Stock, $1 par value 2,519 $0.00 $0.00
Disclosure

SEC source: 0001362109-21-000001 · edgar.xml · nonDerivative · entry 2

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,546

F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:13 UTC
Mason Jeanne KSVP, Human Resources
GrantCommon Stock, $1 par value 688 $0.00 $0.00
Disclosure

SEC source: 0001362109-21-000001 · edgar.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,027

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:12 UTC
Martin SeanSVP and General Counsel
GrantCommon Stock, $1 par value 726 $0.00 $0.00
Disclosure

SEC source: 0001500332-21-000001 · edgar.xml · nonDerivative · entry 4

Martin Sean · CIK 0001500332 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,990

F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021).

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:12 UTC
Martin SeanSVP and General Counsel
Tax withholdingCommon Stock, $1 par value 2,552 $77.80 $198,545.60
Disclosure

SEC source: 0001500332-21-000001 · edgar.xml · nonDerivative · entry 3

Martin Sean · CIK 0001500332 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,264

F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:12 UTC
Martin SeanSVP and General Counsel
GrantCommon Stock, $1 par value 3,225 $0.00 $0.00
Disclosure

SEC source: 0001500332-21-000001 · edgar.xml · nonDerivative · entry 2

Martin Sean · CIK 0001500332 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,816

F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.